Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Der Internist|September 10, 2005
[Lipid lowering drug and other toxic myopathies]B G H Schoser, D PongratzActa Neurologica Scandinavica|April 10, 2002
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibersB G H Schoser, D Blottner, H-J StuerenburgEuropean Neurology|June 15, 2006
Serum levels of matrix metalloproteinases-2 and -9 and their tissue inhibitors in inflammatory neuromuscular disordersS Hurnaus, W Mueller-Felber, D Pongratz, et al.Neuromuscular Disorders : NMD|November 18, 2005
Mutations in mtDNA-encoded cytochrome c oxidase subunit genes causing isolated myopathy or severe encephalomyopathyR Horváth, B G H Schoser, J Müller-Höcker, et al.Neurology|January 26, 2005
Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotypeJ M H Anneser, D E Pongratz, T Podskarbi, et al.Neurology|March 1, 2006
Outcome and effect of pregnancy in myotonic dystrophy type 2S Rudnik-Schöneborn, C Schneider-Gold, U Raabe, et al.Neuropathology and Applied Neurobiology|June 19, 2007
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisitedB G H Schoser, J Müller-Höcker, R Horvath, et al.European Journal of Neurology|February 24, 2006
Prediction of response to IVIg treatment in patients with lower motor neurone disordersN Strigl-Pill, A König, M Schröder, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2004
Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle diseaseP Y K Van den Bergh, J M Gérard, J A Elosegi, et al.Neurology|December 30, 2004
Sudden cardiac death in myotonic dystrophy type 2B G H Schoser, K Ricker, C Schneider-Gold, et al.Pageof 2